Cardiovascular pipeline

Cardiovascular pipeline

Company Product Target Description Indication Status
Alexion/ Procter & Gamble Pexelizumab (5G1.1-SC) Complement 5 (C5) Humanized single chain MAb targeting C5

Read the full 237 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE